TRPV1 and inflammatory bowel disease: RNA-seq analysis showed GPR68 is robustly expressed in Trpv1+ colonic nociceptors and upregulated in tissue from people with inflammatory bowel disease, consistent with reduced disease activity in DSS-treated GPR68-/- mice.